Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
EBioMedicine ; 39: 520-530, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30502052

ABSTRACT

BACKGROUND: Circulating estrogen (E2) levels are high throughout pregnancy and increase towards term, however its local tissue specific actions vary across gestation. For example, myometrial E2 regulated uterotonic action is disabled until term, whereas it's proliferative function is maintained in the breast. We have identified gestationally regulated splicing events, mediated by hnRNPG and modulated by E2 that generate alternatively spliced estrogen receptor alpha (ERα) variants (ERΔ7 and ERα46) in the myometrium. These variants allow for differential, gestationally regulated, modulation of the uterotonic action of E2. METHODS: Human myometrium isolated from preterm and term non-laboring and laboring pregnant women were analyzed for ERα isoforms and splice factor levels. Lentiviral mediated shRNA knockdown of hnRNPG and overexpression of ERΔ7 were performed in human myometrial (hTERT-HM) cells. Functional 3D collagen contraction assays were executed. FINDINGS: ERΔ7 acts as a dominant negative repressor of the uterotonic action of ERα66 and ERα46 isoforms through the regulation of the myometrial gap junction protein GJA1. Elimination of hnRNPG inhibits the generation of ERΔ7 while overexpression of ERΔ7 inhibited GJA1 expression. Moreover in vivo human myometrial hnRNPG levels decline at term in an E2 dependent manner resulting in a withdrawal of ERΔ7 levels and its tocolytic action at term. INTERPRETATION: Our findings implicate the unique role of ERΔ7 as a modulator of myometrial quiescence and define the mechanism of ERΔ7 generation, through hormonally regulated splicing events. FUND: This study was supported by NIH OPRU U01 supplement (HD047905), University of Pittsburgh and Wayne State University Perinatal Research Initiative (USA).


Subject(s)
Connexin 43/metabolism , Estrogen Receptor alpha/genetics , Estrogen Receptor alpha/metabolism , Heterogeneous-Nuclear Ribonucleoproteins/genetics , Myometrium/metabolism , Uterine Contraction/metabolism , Alternative Splicing , Cell Line , Estrogens/metabolism , Exons , Female , Gene Expression Regulation , Gene Knockdown Techniques , HEK293 Cells , Heterogeneous-Nuclear Ribonucleoproteins/metabolism , Humans , Myometrium/cytology , Organ Specificity , Pregnancy , Protein Isoforms/metabolism , Uterine Contraction/genetics , Uterus/metabolism
2.
Cell Death Dis ; 9(10): 933, 2018 09 17.
Article in English | MEDLINE | ID: mdl-30224704

ABSTRACT

The prevention of apoptotic caspase 3 activation through biological preconditioning, mediated through the modulation of the unfolded protein response has been demonstrated to ameliorate multiple pathophysiologies. The maintenance of non-apoptotic caspase 3 activity by the unfolded protein response within the pregnant uterus has previously been proven to be critical in inhibiting uterine myocyte contractility during pregnancy. Here we report that the pregnant uterus utilizes an unfolded protein response-preconditioning paradigm to conserve myometrial caspase 3 in a non-apoptotic state in order to effectively inhibit uterine contractility thereby preventing the onset of preterm labor. In the absence of appropriate endogenous preconditioning during pregnancy, uterine caspase 3 is transformed from a non-apoptotic to an apoptotic phenotype. Apoptotic caspase 3 activation results in the precocious triggering of local uterine inflammatory signaling and prostaglandin production, consequently resulting in an increased incidence of preterm birth. These findings represent a paradigm shift in our understanding of how preconditioning promotes the maintenance of uterine non-apoptotic caspase 3 action during pregnancy preventing the onset of premature uterine contraction and therefore defining the timing of the onset of labor.


Subject(s)
Caspase 3/metabolism , Myometrium/cytology , Myometrium/metabolism , Unfolded Protein Response/physiology , Uterus/cytology , Uterus/metabolism , Animals , Apoptosis/genetics , Apoptosis/physiology , Caspase 3/genetics , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Female , Humans , Mice , Pregnancy , Signal Transduction/genetics , Signal Transduction/physiology , Unfolded Protein Response/genetics
3.
J Cardiovasc Pharmacol Ther ; 22(4): 337-346, 2017 07.
Article in English | MEDLINE | ID: mdl-28376665

ABSTRACT

A broad definition of preconditioning is "the preparation for a subsequent action." Mounting evidence demonstrates that novel remote preconditioning paradigms, in which protective stimuli experienced locally can capacitate systemic tolerance and enhanced cell viability upon exposure to ensuing cellular insults, have been largely successful in the field of cardiovascular ischemia/reperfusion injury. To ensure successful protective preconditioning, some models (including the uterus) have been demonstrated to activate the unfolded protein response (UPR), which is a cellular stress response controlled at the level of the endoplasmic reticulum. However, in the context of remote preconditioning, activation of these intracellular molecular pathways must result in the extracellular transmission of adaptive signals to remote targets. In our recently published manuscript, we have described the activation of the UPR in the pregnant uterine myocyte to be associated with increased uterine myocyte quiescence and normal gestational length. We hypothesize that ubiquitous uterine gestational stresses experienced in every pregnancy, which have been demonstrated in other systems to activate the UPR, may induce a robust paracrine dissemination of a uterine secretome, for example, glucose-regulated protein 78, with preconditioning-like properties. Furthermore, we speculate that the gestational stress-induced uterine secretome acts to promote both local and systemic tolerance to the ensuing gestational insults, allowing for the maintenance of uterine quiescence. In this context, preterm labor may be the result of a pregnant uterus experiencing a stress it cannot accommodate or when it is unable to host an appropriate UPR resulting in insufficient preconditioning and a diminished local and systemic capacity to tolerate pregnancy-dependent increases in normal gestational stress. This is highly attractive from a clinical viewpoint as we ultimately aim to identify local and systemic adaptations that may serve as preconditioning stimuli for use as a strategy to restore appropriate preconditioning profiles to prolong uterine quiescence in pregnancy.


Subject(s)
Ischemic Preconditioning/methods , Premature Birth/prevention & control , Uterine Contraction , Uterus/physiopathology , Adaptation, Physiological , Animals , Blood Flow Velocity , Endoplasmic Reticulum Chaperone BiP , Female , Heat-Shock Proteins/metabolism , Humans , Pregnancy , Premature Birth/metabolism , Premature Birth/physiopathology , Regional Blood Flow , Signal Transduction , Unfolded Protein Response , Uterus/blood supply , Uterus/metabolism
4.
Biol Reprod ; 95(6): 120, 2016 12.
Article in English | MEDLINE | ID: mdl-27733380

ABSTRACT

There is considerable evidence that implicates oxidative stress in the pathophysiology of human pregnancy complications. However, the role and the mechanism of maintaining an antioxidant prosurvival uterine environment during normal pregnancy is largely unresolved. Herein we report that the highly active uterine unfolded protein response plays a key role in promoting antioxidant activity in the uterine myocyte across gestation. The unfolded protein response (UPR) senses the accumulation of misfolded proteins in the endoplasmic reticulum (ER) and activates a signaling network that consists of the transmembrane protein kinase eukaryotic translation initiation factor 2 alpha kinase 3/PKR-like-ER kinase (EIF2AK3), which acts to decrease protein translation levels, allowing for a lowered need for protein folding during periods of ER stress. However, independent of its translational regulatory capacity, EIF2AK3-dependent signals elicit the activation of the transcription factor, nuclear factor erythroid 2-like 2 (NFE2L2) in response to oxidative stress. NFE2L2 binds to antioxidant response elements in the promoters of a variety of antioxidant genes that minimize the opportunities for generation of reactive oxygen intermediates. Our analysis demonstrates that in the absence of EIF2AK3, the uterine myocyte experiences increased levels of reactive oxygen species due to decreased NFE2L2 activation. Elevated levels of intracellular reactive oxygen species were observed in the EIF2AK3 null cells, and this was associated with the onset of apoptotic cell death. These findings confirm the prosurvival and antioxidant role of UPR-mediated EIF2AK3 activation in the context of the human uterine myocyte.


Subject(s)
Endometrium/metabolism , Muscle Cells/metabolism , Oxidative Stress/physiology , Reactive Oxygen Species/metabolism , Unfolded Protein Response/physiology , Uterus/metabolism , Animals , Apoptosis/physiology , Cell Line , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum Stress/physiology , Female , Humans , Mice , NF-E2-Related Factor 2/metabolism , Pregnancy , Protein Folding , eIF-2 Kinase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...